Europe adopted a new Code of Ethical Business Practice late last year. This article explores the purpose of the new Code, standards found in the new code, as well as some material differences between this new Code and other Codes currently in existence.
The February issue of Life Science Compliance Update (“Update”) reviewed a new code of conduct from the European Generic Medicines Association (EGA) In the March issue, the Update highlighted and compared some the major codes life sciences compliance officers regularly deal.
Now it appears that there is yet another new code that at least medical device compliance officers need to consider. On December 2, 2015, members of both the European Diagnostic Manufacturers Association (“EDMA”) and the European Medical Technology Industry (“Eucomed”) approved a new Code of Ethical Business Practice. Both associations are members of MedTech Europe who is working to raise the ethical standards of the medical technology industry all throughout Europe.
The full text of this article is available in the May 2016 Issue of Life Science Compliance Update